JUBLPHARMA — Jubilant Pharmova Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Jubilant Pharmova, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	12,105	8,711	6,304	278	1,705
Depreciation
Non-Cash Items	2,988	6,058	1,978	2,288	3,735
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,283	-2,212	-3,724	-1,500	454
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	15,429	17,073	8,375	6,607	9,713
Capital Expenditures	-5,742	-5,275	-6,000	-8,144	-8,977
Purchase of Fixed Assets
Other Investing Cash Flow Items	2,472	-2,115	2,196	2,700	2,898
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-3,270	-7,390	-3,804	-5,444	-6,079
Financing Cash Flow Items	-3,250	-2,922	-1,349	-2,342	-2,437
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-10,504	-17,094	-326	-1,567	-4,325
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,254	-7,289	4,819	301	-575